argenx Cash from Financing (Quarterly) Analysis

argenx SE (ARGX)

1023.21 -35.69 (-3.37%) USD | NASDAQ | Aug 28, 16:00

1023.05 -0.16 (-0.02%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ARGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Financing (Quarterly) Chart

Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2014. Start Trial.

Date	Value
June 30, 2014	0.00

Date	Value
March 31, 2014	0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks

Start Trial

Autolus Therapeutics Plc	-2.144M
Akari Therapeutics Plc	8.034M
Forte Biosciences, Inc.	161.95M
Evaxion AS	--
DBV Technologies SA	-0.1356M

Cash from Financing (Quarterly) Related Metrics

Free Cash Flow	1.090B
Free Cash Flow Yield	1.63%